Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 208 participants.
Also called NCT06096246
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 208 participants
- Sponsor
- Registry
-
NCT06096246
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT06096246. Randomized; double masking; primary purpose treatment. Start 2024-07-26 (actual); primary completion 2027-07-26 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)
- Acronym
- ORBICA-AF
- Condition
- Persistent Atrial Fibrillation
- Condition
- Cardiac Arrhythmia
- Condition
- Catheter Ablation
- Intervention (Procedure)
- Pulmonary vein isolation
- Intervention (Procedure)
- DC Cardioversion
- Intervention (Device)
- Implantable loop recorder
- Intervention (Procedure)
- Femoral sheath insertion
- Lead sponsor
- Barts & The London NHS Trust
Record details
- Record id
cardio:ct-nct06096246- Content hash
eca12c648236f34ae4cfd99975e3fa85ef83556e0f6df2531af3c4040557978e